Welcome to the Precision Cancer Consortium
Driving Global Access to Comprehensive Genomic Profiling for all Patients with Cancer, the Precision Cancer Consortium (PCC) aims to make precision oncology and comprehensive genomic profiling the new normal
2024, Year in Review
"Our vision is to make precision oncology and CGP the new normal – only together can we achieve this." A message from Precision Cancer Consortium Chair
Modified genomic testing cost calculator available for FREE download
The PCC, along with IQVIA, have redeveloped the genomic testing cost calculator to incorporate testing costs in USD.
PCC Wayfinder winners 2025
Celebrating PCC Wayfinders: driving impact to advance precision oncology
A Collaboration to Address Challenges Associated with Precision Oncology
Challenges that are ecosystem related cannot be solved by one stakeholder of the healthcare system alone. The PCC facilitates collaboration of pharma/biotech companies to address challenges regarding access, awareness, and research and development of comprehensive genomic testing for cancer patients globally.
PCC Strategic Objectives
1
Access
Increase patient access to comprehensive genomic profiling (CGP) in both routine care and research, globally
2
Educate
Educate stakeholders and increase awareness on how CGP can improve patient outcomes
3
Address
Address the challenges of implementing CGP in healthcare systems to improve equitable access to testing
PCC Members
The PCC are a group of seven pharmaceutical companies with a shared vision, coming together to address challenges regarding access, awareness, and research & development of comprehensive genomic testing for cancer patients globally.
The PCC is a non-profit organization.
The latest from PCC
PCC shortlisted for the Precision Medicine Awards
We’re pleased to share that the Precision Cancer Consortium (PCC) has been shortlisted for the Precision...
Modified genomic testing cost calculator available for FREE download
The PCC, along with IQVIA, have redeveloped the genomic testing cost calculator to incorporate testing...
2024, Year in Review
"Our vision is to make precision oncology and CGP the new normal – only together can we achieve this."...
PCC has initiated a new project with healthcare specialists Avalere Health
PCC has initiated a new project with healthcare specialists Avalere Health to drive the implementation...
Japan Precision Cancer Think Tank 2024
A key mission of the Precision Cancer Consortium’s (PCC) education and awareness workstream is to uncover...
PCC has initiated a new project with strategy consulting specialists DeciBio
PCC has initiated a new and exciting project with strategy consulting specialists DeciBio
Revolutionizing Cancer Trial Matching: PCC and Massive Bio’s AI-driven Multi-sponsor Study Delivers Promising Results
June 2024, ASCO Annual Meeting, Chicago – The Precision Cancer Consortium (PCC), in partnership with...
Unique clinical trial matching initiative increases patient eligibility for trials
The problem: Clinical research teams manually match patients one-trial-at-a-time, taking approximately...
